Article metrics

PDF

Original article
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal

Statistics from Altmetric.com

Online download statistics by month:

AbstractFullPDF
Jan 2017676359277
Feb 201785224197
Mar 20170236134
Apr 20173313154
May 20172281118
Jun 201761252120
Jul 2017247247129
Aug 2017727725270
Sep 2017373374158
Total217430111557